insights_auto
Nega 600812 tushdi 4,72%?
Batafsil oʻrganishchevron_right
600812:SHA
North China Pharmaceutical Co Ltd
6,26 CN¥
arrow_downward
-4,72%(-0,31) 1K
16-okt, 15:00:00 (GMT+8) · CNY
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto600812 tikeri uchun statistika yaratilmoqda...
Ochish
6,33 CN¥
Yuqori
6,90 CN¥
Past
6,10 CN¥
Oʻrtacha hajm
61,12 mln
Hajmi
307,76 mln
Dividend
0,56%
Choraklik dividendlar
0,01 CN¥
Eks-dividend sanasi
11-iyn, 2026
P/E koeffitsiyenti
87,26
52 haftalik eng yuqori
6,90 CN¥
52 haftalik eng past
4,11 CN¥
Aksiya boʻyicha daromad
0,07 CN¥
Muomaladagi aksiyalar
1,63 mlrd
Xodimlar soni
10 ming
Ochish
6,33 CN¥
Yuqori
6,90 CN¥
Past
6,10 CN¥
Oʻrtacha hajm
61,12 mln
Hajmi
307,76 mln
Dividend
0,56%
Choraklik dividendlar
0,01 CN¥
Eks-dividend sanasi
11-iyn, 2026
P/E koeffitsiyenti
87,26
52 haftalik eng yuqori
6,90 CN¥
52 haftalik eng past
4,11 CN¥
Aksiya boʻyicha daromad
0,07 CN¥
Muomaladagi aksiyalar
1,63 mlrd
Xodimlar soni
10 ming
Aloqador aksiyalar
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
GlobeNewswire
·
40 daqiqa oldin
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Business Wire
·
1 soat oldin
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launched
marketscreener.com
·
4 daqiqa oldin
CECO Environmental Corp. Primary Exchange Listing will Change to Texas Stock Exchange from Nasdaq Global Select
Bloomberg.com
·
2 soat oldin
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profil
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
North China Pharmaceutical Co Ltd haqida
CEO-
Xodimlar soni9,97 ming
Asos solingan20-dek, 1992
Bosh ofislar-
Sektor-
Veb-sayt-